Categories
Cannabis Events Press Releases

Earth Science Tech LTD (ETST) Considers Dual Listing of its Common Shares on the Canadian Securities Exchange (CSE)

DORAL, Florida, Dec. 11, 2018 (GLOBE NEWSWIRE)

Earth Science Tech LTD. (OTCQB: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces that as the Company is now an “OTC reporting issuer” in the Province of Québec, Canada, its board of directors is considering a dual listing of its common shares on the Canadian Securities Exchange (CSE).

Earth Science intends to file an application with the CSE in early 2019. Listing could happen as early as in the third quarter of the Company’s current fiscal year and would require certain regulatory approvals that would allow Earth Science to market and sell its common shares to Canadian investors.

“The Canadian Securities Exchange has seen significant increases in trading, particularly in the cannabis and CBD space. We feel that by listing on the two exchanges we will attract more investors in both the U.S. and Canada, creating further liquidity and increasing our ability to raise capital in a different market. With our R&D operations conducted in Canada and our CEO residing in Canada, considering a listing on the CSE makes the most sense,” states Earth Science president, director and Chairman Nickolas S. Tabraue.

Categories
In the News Latest News

2018 Cannabis Conference: Seeking Higher Ground

Philadelphia, Pennsylvania: Over 700 Gather for Philadelphia’s First Cannabis Opportunity Conferencehosted by Senator Street & DACO, Diasporic Alliance for Cannabis Opportunities

PHILADELPHIA, PA -‘2018 Cannabis Conference: Seeking Higher Ground’,PA Senator Sharif Street, 3rd District joined the Diasporic Alliance for Cannabis Opportunities(DACO) to host a two-day conference on the emerging opportunities in the Cannabis Industry for marginalized communities on Friday, October 19th and Saturday, October 20th, 2018 at Temple University Medical School located at 3500 N. Broad Street, Philadelphia, PA 19140.

 

The event which drew over 700 participants in two days was hosted by The Diasporic Alliance for Cannabis Opportunities and opened with a  welcome address by Philadelphia Mayor Jim Kenney and a message on Social Justice from US Senator Cory Booker. Senator Street and  DACO aims to open the dialogue for opportunities in education, wellness, social justice, policy, entrepreneurship and workforce development. A diverse group of exhibitors and speakers converged to offer a variety of programming including a job fair, legislative panel of past and pending cannabis reform, expungement clinic and more.

 

PA Senator Sharif Street (3rd District) added, “The issues of cannabis reform are economic issues, social justice issues and equity. The absurdity and history of US Drug Policy has been imbedded in the prohibition of cannabis and driven by the overincarceration of black and brown communities.  I am proud to offer legislation to decriminalize cannabis at the state level. I am proud to offer my office to constituents to sign up for Medical Marijuana cards and I am proud to join DACO in educating and empowering our communities to participate in this emerging industry. It is time for Pennsylvania to grow its economy and legalize cannabis in a fair, just and equitable way. ”

 

Cheron Perry-Thomas Co-founder and Chief Executive Officer, of the Diasporic Alliance for Cannabis Opportunities (DACO) said, “The 2018 Cannabis Opportunities Conference did what it set out to do which was to bring awareness of opportunities in cannabis to our communities.  Desiree Ivey and I have received much positive feedback about the education and networking opportunities. We were able to bring elected officials, experts, lawyers, doctors and community stakeholders together to ask questions, and learn about the cannabis as an entry to wellness and for economic empowerment.”

 

“The success of the very first Diasporic Alliance for Cannabis Opportunities Conference (DACO) shows nothing but how promising and beneficial this industry is on a number of levels – including medicinal, economic and entrepreneurial,” said Councilman Derek S. Green (At-Large). “I’m grateful to State Senator Sharif Street, as well as to the members of DACO for inviting me to be part of this endeavor. I look forward to future conversation and collaboration on this front.”

Categories
Cannabis Oils Drug Addiction Hemp Oil In the News Latest News Medical Opioid Addiction Press Releases

Earth Science Tech Finalizes Plans for Human Trials on New CBD-Based Formula Targeting Opioid Addiction Epidemic

Doral, FL, February 28, 2018 (GLOBE NEWSWIRE) – Earth Science Tech (OTC PINK: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announced it has finalized plans for a 9-month human trial to assess the efficacy of its treatment combining an essential mineral element and full-spectrum cannabinoid industrial hemp oil. This is expected to increase potency as opposed to the status quo in the market today, which consists solely of essential mineral element therapy (monotherapy) in treating patients with morbid substance abuse and/or dependence. These plans were originally announced in late 2017. The purpose of this trial is to develop a methodology for treating opioid addicts, preventing fatal overdoses, and relieving side-effects from withdrawals.

The new study takes advantage of two of the properties of ETST’s full-spectrum cannabinoids industrial hemp oil that have already shown great success against addiction, based on positive feedback from customers and doctors alike. The full-spectrum cannabinoids has great potential to mix with the essential mineral element, because it can support and increase the action of other drugs and medicinal substances, offering tremendous synergy. Many promising clinical studies are ongoing around the world, with cannabinoids being a key research topic for the substance abuse treatment and psychological disorders.

The 9-month human trial will study substance abuse patients who had drug prescription treatment or dietary supplement monotherapy, full-spectrum cannabinoid monotherapy, and a combination of full-spectrum cannabinoids and a dietary supplement molecule. The patient will receive this treatment sequentially. The first three months with drug prescription treatment monotherapy or dietary supplement monotherapy, the second three months with drug prescription or dietary supplement combined with full-spectrum cannabinoids, and the last 3 months with full-spectrum cannabinoids and hemp oil.  

The choice of the molecule that will be combined with the full-spectrum cannabinoids have selected after months of meticulous due diligence. The project will test the additive nature of full-spectrum cannabidnoids with two different forms of an essential mineral element, which will be revealed soon.

Should the potential synergies between the essential mineral element and cannabinoids (mainly CBD) prove successful, as the company is confident that it will, then ETST will be positioned to bring an innovative new products to the marketplace to counteract the scourge of opioid deaths that is sweeping the US. Earth Science Tech envisions and plans on producing a nutraceutical product that could be sold over the counter to help addicts resist cravings, and a cannabinoid companion for a generic drug to make the treatment more effective and reduce the danger, toxicity, and side-effects.

The Company’s CLO, Gabriel Aviles, and CEO/CSO, Dr. Michel Aube, will be supervising the project along with the medical professional advisory board team providing their resources for the human trials. The project time frame and goal is set to be completed, along with white paper studies by early 2019. This will encourage the Company to pursue clinical studies for at least two years through the remainder of 2019 and 2020, pioneering the never before attempted research studies on these two compounds combined.

ETST is currently communicating with their third-party CGMP laboratory on  mixing the anti-opioid formula for human trials, and are in talks with rehab centers interested in participating in the study to some capacity. The Company plans on sharing updates as they progress.

 

About Earth Science Tech (ETST): Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit: www.earthsciencetech.com

 

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases). Earth Science Pharmaceutical CEO Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.EarthSciencePharmaceutical.com

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals, as well as other products & solutions. Cannabis Therapeutics’ mission it to help change the health care landscape by introducing its proprietary cannabis-cannabinoid-based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.CannabisThera.com

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.KannaBidioiDInc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Dave Demarest (305) 546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305) 615-2118

Categories
Cannabis Oils Cannabis Plant Hemp Oil In the News Industrial Hemp Latest News Marketing Press Releases Top Stories

Earth Science Tech Announces Highly Anticipated New Revamp Industrial Hemp Products Launch Date & Forecasts Highest Grossing Month

Doral, FL, February 8, 2018 (GLOBE NEWSWIRE) – Earth Science Tech (OTC PINK: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces launch date on the Company’s highly anticipated new revamp industrial hemp products and forecasts highest grossing month.

Monday, February 12, 2018 is the official launch dat foe the Company’s highly anticipated High Grade Full Spectrum Cannabinoids new revamp products and marketing strategy, announced early December 2017.

High Grade Full Spectrum Cannabinoids is composed of Netherland CO2 supercritical extracted organically grown unfiltered industrial hemp. The Company originally was planning on using American industrial hemp but, was able to secure a reliable high quality source in Europe to continue offering European industrial hemp causing the slight delay in launching. ETST will be one of the first companies to market it’s industrial hemp product as a Cannabinoid Complex, disclosing the mgs of each Cannabinoid, (CBD, CBDV, CBG, CBC, CBN, & CBDA). Cannabinoid complex is naturally occurring in the 7% CBD industrial hemp plant used and is rich in Terpenes, and Saponins as well. Mixed, bottled,  and packaged in the U.S. at a CGMP facility, the Company’s High Grade Full Spectrum Cannabinoids offer the highest consistent quality that current end users trust and carry forward. Preorders are being accepted online.

Since the announcement last year on our new revamp, Mr. Checkout distributor launched last week, and new veteran Chef Sales Officer, (CSO), the exponential demand has the Company forecast the highest revenue month to date. The Company currently has new chain stores, clinics, and health shops eagerly waiting for the launch to place their orders.

Nickolas S. Tabraue, ETST’s president, director and COO concludes, “the feedback alone  the visual have been positively overwhelming. Thanks to our new CSO our sales effective growing sales team along with our CLO’s product education guidance we look have a grand presence domestically and truly stand out in the CBD industry. I would like to update our stakeholders that our audit looks to be done by the end of next week followed by the Tier II Reg A+ submission and plan on announcing completion as well as other materials progress ”

About Earth Science Tech (ETST): Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit: www.earthsciencetech.com

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases). Earth Science Pharmaceutical CEO Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.EarthSciencePharmaceutical.com

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals, as well as other products & solutions. Cannabis Therapeutics’ mission it to help change the health care landscape by introducing its proprietary cannabis-cannabinoid-based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.CannabisThera.com

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.KannaBidioiDInc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Dave Demarest (305) 546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305) 615-2118

Categories
Cannabis Oils Hemp Oil In the News Industrial Hemp Latest News Marketing Press Releases

Earth Science Tech Announces Launch Dates & Forecasts for Highly-Anticipated, Revamped Industrial Hemp Products

Doral, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) — Earth Science Tech (OTC PINK: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announced launch date for the Company’s highly-anticipated, revamped industrial hemp Cannabidiol (CBD) products, which lead to forecast updates reflecting to a record-high monthly revenue.

February 13, 2018 is the official launch date for the Company’s highly anticipated High Grade Full Spectrum Cannabinoids product, and corresponding marketing strategy, announced early December 2017.

High Grade Full Spectrum Cannabinoids is composed of European CO2, supercritical extracted, organically grown, and unfiltered industrial hemp. The Company was originally planning on using American industrial hemp but was able to secure a reliable high-quality source in Europe to continue offering European industrial hemp, which led to slight delays from the original launch time frame. ETST will be one of the first companies to market its industrial hemp product as a Cannabinoid Complex instead of CBD, disclosing the milligrams (mg) of each Cannabinoid (CBD, CBDV, CBG, CBC, CBN, & CBDA). Cannabinoid complex is naturally occurring in the industrial hemp plant used, and is rich in Terpenes, and Saponins. Mixed, bottled, and packaged in the U.S. at a CGMP facility, the Company’s High Grade Full Spectrum Cannabinoids offer the highest therapeutic quality that current end-users trust and carry forward. Preorders are currently being accepted online.

Since last year’s announcement on product and marketing strategy revamp, Mr. Checkout distributor launched last week, and new veteran Chef Sales Officer, (CSO), the exponential demand increase has led the Company to revise forecasts to reflect what is anticipated to be the highest revenue month to date. The Company has new chain stores, clinics, and health shops eagerly waiting for the official launch to place their initial orders.

Nickolas S. Tabraue, ETST’s president, director and COO concludes, “Between appointing a new Chief Sales Officer, launching revamped industrial hemp products with fresh branding and marketing strategies, and our new distributor Mr. Checkout, we are on track for a record-setting revenue month. We’ve made clear that we intend to make 2018 our breakout year, and we are laying a strong foundation in this first quarter. We will continue to provide updates on our material events as we can.”

“While much of the up-listing and Reg A+ offering processes are out of our hands, we want to reassure our shareholders that we have worked hard to prepare the required paperwork for our audit and offering filings. We are prioritizing transparency and creating lasting value for our stakeholders and are committed to up-listing to the QB tier of the OTC Markets this year. We will provide updates as progress is made.”

Categories
In the News Latest News Press Releases Top Stories

Earth Science Tech Achieves Q1 Goal with Expansion of Executive Leadership Team

Doral, FL, February 1, 2018 (GLOBE NEWSWIRE) – Earth Science Tech (OTC PINK: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabinoid (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces the appointments of a new chief sales officer (CSO), chief financial officer (CFO), and chief learning officer (CLO).

As part of ETST’s previously announced goals for the first quarter of 2018, the Company has expanded its core executive team to now include Jill Buzan as CSO, Wendell Hecker as CFO, and prior CSO Gabriel Aviles to the role of CLO to maximally leverage strengths and lead to bottom-line growth in 2018.

CSO Buzan, an established veteran of the natural product sales industry, began her successful career as a sales rep and broker in Florida in 1995. She has pioneered many brands and helped them grow and become leaders in the industry including Gaia Herbs, Natural-Immunogenics and Sunwarrior. She loves taking outstanding products to  market! Her passion since 1979 has been natural health and healing through food, supplements, exercise, lifestyle and helping others achieve their full potential on all levels, physically, emotionally, mentally and spiritually. Her sales strength, and financial success comes from this passion and using an education based and consultative sales approach with her customers. Her intention with ETST is to create a dynamic group of sales  people who, together, can make ETST the top-selling CDB company in the industry. Jill already has multiple chain store accounts lined up for the Company’s revamped line, which is launching within the first week of February.

Buzan states, “Having worked with so many budding natural products brands, I know what it takes for a company to find success in this market, and ETST has it. The executive team is motivated, hard-working, and talented. I will be building a strong sales team this year, and we envision opening a record number of new accounts in 2018.”

CFO Hecker achieved a Bachelor of Science in Accounting from New York University. Having spent more than 30 years at large corporations in New York and Florida, he brings to ETST extensive accounting experience. Hecker will ensure that the Company’s accounting follows best practices, keeps up-to-date, and increases transparency with investors as sales continue to increase. He will help also the Company maintain compliance when up-listed to the OTCQB exchange.

Hecker comments, “This company is on the cusp of increasing sales dramatically. It’s the right time to get the books in order and ensure compliance as the company grows and joins the QB Tier of the OTC Markets.”

Aviles, the Company’s current CSO, will transition to the role of CLO to help further educate store owners and clients, assist in the new foundation, and help build brand integrity. Aviles plans to publish articles, record informative videos, conduct webinars, attend conferences, and help educate the Company’s growing sales team to provide the informative service to accounts.

Aviles shares, “Education puts me in my element. While I enjoyed my time as the CSO, I feel I will have much more impact on helping the company grow as the CLO, and Ms. Buzan definitely has what it takes to lead our organization’s sales efforts to the next level.”

Nickolas S. Tabraue, ETST’s president, director and COO concludes, “I have been extremely fortunate to have found hard working like-minded individuals to work together and achieve our company’s overarching vision. The year has only just begun, and we are already looking very strong. I expect to have a lot of exciting updates to share with our stakeholders very soon.”

About Earth Science Tech (ETST): Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit: www.earthsciencetech.com

About Earth Science Pharmaceutical: Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases). Earth Science Pharmaceutical CEO Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.EarthSciencePharmaceutical.com

About Cannabis Therapeutics: Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech (ETST). Cannabis Therapeutics was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals, as well as other products & solutions. Cannabis Therapeutics’ mission it to help change the health care landscape by introducing its proprietary cannabis-cannabinoid-based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.CannabisThera.com

About KannaBidioiD: KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech (ETST). KannaBidioid is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.KannaBidioiDInc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Dave Demarest (305) 546-7640

Earth Science Tech Nickolas S. Tabraue, P/D/COO (305) 615-2118

Corporate Communications Contact: 
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com